Clinical trials
Completed Phase 3 Breast Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 2 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ain Shams University | 1 |
| BioNumerik Pharmaceuticals, Inc. | 1 |
| Hanlim Pharm. Co., Ltd. | 1 |
| Hoffmann-La Roche | 1 |
| Mayo Clinic | 1 |
| NSABP Foundation Inc | 1 |
| Nova Scotia Health Authority | 1 |
| Novartis Pharmaceuticals | 1 |
| University College, London | 1 |
| Uppsala University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Diseases | 10 |
| Breast Neoplasms | 7 |
| Neoplasms | 4 |
| Neoplasms by Site | 3 |
| Carcinoma | 2 |
| Adenocarcinoma | 1 |
| Agnosia | 1 |
| Multiple Endocrine Neoplasia Type 1 | 1 |
| Neoplasm Metastasis | 1 |
| Neurotoxicity Syndromes | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.